<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01023451</url>
  </required_header>
  <id_info>
    <org_study_id>091007</org_study_id>
    <nct_id>NCT01023451</nct_id>
  </id_info>
  <brief_title>Serum Brain Natriuretic Peptide Levels and Pulmonary Hypertension in Pediatric Sickle Cell Patients</brief_title>
  <official_title>Serum Brain Natriuretic Peptide Levels and Its Correlation With Echocardiographic Measurements Suggestive of Pulmonary Hypertension in Pediatric Patients With Sickle Cell Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akron Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akron Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is

        1. To determine if Brain natriuretic peptide levels correlates with elevated tricuspid
           regurgitation flow velocity levels in pediatric patients with sickle cell disease

        2. To determine the role of age, gender, steady state hemoglobin and disease type on Brain
           natriuretic peptide levels and pulmonary hypertension
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary hypertension is recognized as a significant cause of morbidity and mortality in
      patients with sickle cell disease. Doppler echocardiography is a recommended noninvasive
      screening tool for sickle cell disease patients with pulmonary hypertension. Brain
      natriuretic peptide levels have been found to be a possible serum screening marker. This
      research will offer the opportunity to determine if there is any possible relationship
      between magnitude of BNP concentration and degree of TRV, if it can be used as a screening
      test in SCD pediatric patients with PHT and form the basis for a future multicenter study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">June 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation of Brain Natriuretic Peptide (BNP) levels to elevated Tricuspid Regurgitation Flow Velocity (TRV)</measure>
    <time_frame>one day</time_frame>
    <description>Subjects will be asked to participate in the study by allowing a review of their echocardiographic findings. In addition, they will be asked for a 1 ml blood sample during routine annual follow ups for BNP levels to be drawn.</description>
  </primary_outcome>
  <enrollment type="Actual">21</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Sickle cell clinic
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and Female any age

          -  Diagnosis of SCD with PHT on echocardiogram

          -  Controls must have a diagnosis of sickle cell disease without Pulmonary hypertension,
             age, gender and disease type match to subjects with pulmonary hypertension

          -  Parent or Legal guardian willing to sign informed consent form

        Exclusion Criteria:

          -  Abnormal echocardiograms not related to PHT

          -  Parent or Legal guardian unwilling or unable to give written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Do, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Akron Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey Hord, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Akron Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Akron Children's Hospital Sickle Cell Clinic</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004 Feb 26;350(9):886-95.</citation>
    <PMID>14985486</PMID>
  </reference>
  <reference>
    <citation>Ataga KI, Sood N, De Gent G, Kelly E, Henderson AG, Jones S, Strayhorn D, Lail A, Lieff S, Orringer EP. Pulmonary hypertension in sickle cell disease. Am J Med. 2004 Nov 1;117(9):665-9.</citation>
    <PMID>15501204</PMID>
  </reference>
  <reference>
    <citation>Suell MN, Bezold LI, Okcu MF, Mahoney DH Jr, Shardonofsky F, Mueller BU. Increased pulmonary artery pressures among adolescents with sickle cell disease. J Pediatr Hematol Oncol. 2005 Dec;27(12):654-8.</citation>
    <PMID>16344670</PMID>
  </reference>
  <reference>
    <citation>Nelson SC, Adade BB, McDonough EA, Moquist KL, Hennessy JM. High prevalence of pulmonary hypertension in children with sickle cell disease. J Pediatr Hematol Oncol. 2007 May;29(5):334-7.</citation>
    <PMID>17483714</PMID>
  </reference>
  <reference>
    <citation>Castro O, Hoque M, Brown BD. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood. 2003 Feb 15;101(4):1257-61. Epub 2002 Oct 3.</citation>
    <PMID>12393669</PMID>
  </reference>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2009</study_first_submitted>
  <study_first_submitted_qc>December 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2009</study_first_posted>
  <last_update_submitted>June 24, 2014</last_update_submitted>
  <last_update_submitted_qc>June 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary hypertension</keyword>
  <keyword>Sickle cell disease</keyword>
  <keyword>Pediatric patients</keyword>
  <keyword>Brain Natriuretic Peptide levels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Natriuretic Peptide, Brain</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

